STOCK TITAN

Amerisafe Financials

AMSF
Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Amerisafe (AMSF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMSF FY2025

A shrinking equity base and weakening cash conversion are now shaping results more than modest revenue movement.

Return on equity remained high at 18.7% in FY2025 even though net income fell to $47.1M, so the headline return metric flatters the underlying earnings trend. That persistence says more about a smaller capital cushion than stronger earning power, because equity has been cut since FY2021 to $251.6M from $399.3M.

The business kept revenue roughly flat, at $306.9M in FY2023 and $317.3M in FY2025, so the profit squeeze was not caused by a collapsing top line. Instead, SG&A expense rose to $33.3M from $27.4M, and net margin narrowed as overhead absorbed more of each revenue dollar.

Cash generation weakened much faster than earnings: operating cash flow fell to $11.1M in FY2025 from $29.8M in FY2023, so accounting profit translated into far less spendable cash. Cash still ended higher at $61.9M because investing inflows of $68.4M offset distributions and other outflows, making liquidity look sturdier than current operations alone.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 27 / 100
Financial Profile 27/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Amerisafe's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
36

Amerisafe's revenue grew a modest 2.7% year-over-year to $317.3M. This slow but positive growth earns a score of 36/100.

Leverage
31

Amerisafe has a moderate D/E ratio of 3.49. This balance of debt and equity financing earns a leverage score of 31/100.

Cash Flow
39

Amerisafe has a free cash flow margin of 2.8%, earning a moderate score of 39/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
56

Amerisafe's ROE of 18.7% shows moderate profitability relative to equity, earning a score of 56/100. This is down from 21.5% the prior year.

Piotroski F-Score Neutral
4/9

Amerisafe passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Low Quality
0.24x

For every $1 of reported earnings, Amerisafe generates $0.24 in operating cash flow ($11.1M OCF vs $47.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$317.3M
YoY+2.7%
5Y CAGR-1.3%
10Y CAGR-2.3%

Amerisafe generated $317.3M in revenue in fiscal year 2025. This represents an increase of 2.7% from the prior year.

EBITDA
N/A
Net Income
$47.1M
YoY-15.0%
5Y CAGR-11.5%
10Y CAGR-3.9%

Amerisafe reported $47.1M in net income in fiscal year 2025. This represents a decrease of 15.0% from the prior year.

EPS (Diluted)
$2.47
YoY-14.5%
5Y CAGR-11.2%
10Y CAGR-3.9%

Amerisafe earned $2.47 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 14.5% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$8.9M
YoY-61.8%
5Y CAGR-32.2%
10Y CAGR-20.8%

Amerisafe generated $8.9M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 61.8% from the prior year.

Cash & Debt
$61.9M
YoY+40.6%
5Y CAGR+0.1%
10Y CAGR-1.1%

Amerisafe held $61.9M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
$1.56
YoY+5.4%
5Y CAGR+7.6%
10Y CAGR+10.0%

Amerisafe paid $1.56 per share in dividends in fiscal year 2025. This represents an increase of 5.4% from the prior year.

Shares Outstanding
19M
YoY-1.3%
5Y CAGR-0.6%
10Y CAGR-0.2%

Amerisafe had 19M shares outstanding in fiscal year 2025. This represents a decrease of 1.3% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
14.8%
YoY-3.1pp
5Y CAGR-10.7pp
10Y CAGR-2.7pp

Amerisafe's net profit margin was 14.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.1 percentage points from the prior year.

Return on Equity
18.7%
YoY-2.8pp
5Y CAGR-1.0pp
10Y CAGR+3.2pp

Amerisafe's ROE was 18.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.8 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$2.1M
YoY+155.7%
5Y CAGR+18.5%
10Y CAGR+8.5%

Amerisafe invested $2.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 155.7% from the prior year.

AMSF Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $80.1M-1.8% $81.6M-0.5% $82.0M+1.1% $81.1M+11.7% $72.6M-1.9% $74.0M-5.9% $78.7M+3.8% $75.8M
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $8.0M-13.1% $9.2M+10.4% $8.3M+11.6% $7.5M-10.0% $8.3M-8.1% $9.0M+16.3% $7.7M+7.0% $7.2M
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax $2.0M-11.3% $2.3M-38.0% $3.7M+4.7% $3.5M+54.0% $2.3M-36.5% $3.6M+3.2% $3.5M+26.1% $2.8M
Net Income $8.1M-21.5% $10.4M-24.9% $13.8M-1.0% $14.0M+55.9% $8.9M-32.0% $13.2M-8.1% $14.3M+30.3% $11.0M
EPS (Diluted) $0.43 N/A $0.72-1.4% $0.73+55.3% $0.47 N/A $0.75+31.6% $0.57

AMSF Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $1.1B-0.7% $1.1B-3.0% $1.2B+0.9% $1.2B-0.1% $1.2B-0.1% $1.2B-7.7% $1.3B+1.7% $1.2B
Current Assets N/A N/A N/A N/A N/A N/A N/A N/A
Cash & Equivalents $34.2M-44.7% $61.9M+13.1% $54.7M+13.0% $48.5M+8.3% $44.8M+1.6% $44.0M-30.8% $63.7M+108.0% $30.6M
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $876.4M-0.3% $878.9M-1.3% $890.2M+0.1% $889.5M-0.7% $895.9M-0.5% $900.5M-4.2% $940.4M+0.8% $932.5M
Current Liabilities N/A N/A N/A N/A N/A N/A N/A N/A
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $246.6M-2.0% $251.6M-8.4% $274.8M+3.5% $265.6M+1.8% $260.8M+1.3% $257.3M-18.1% $314.4M+4.4% $301.0M
Retained Earnings $83.3M+0.5% $82.8M-15.9% $98.5M+6.9% $92.1M+7.6% $85.6M+1.8% $84.1M-37.8% $135.3M+5.7% $128.0M

AMSF Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow -$2.7M-125.4% $10.6M-0.6% $10.7M+226.5% -$8.4M-371.1% -$1.8M-116.6% $10.8M+28.1% $8.4M+426.0% -$2.6M
Capital Expenditures $26K-85.0% $173K-80.6% $891K-17.7% $1.1M+54000.0% $2K-85.7% $14K-41.7% $24K-57.1% $56K
Free Cash Flow -$2.7M-126.1% $10.4M+6.7% $9.8M+202.8% -$9.5M-430.9% -$1.8M-116.6% $10.8M+28.3% $8.4M+418.2% -$2.6M
Investing Cash Flow -$12.5M-140.6% $30.7M+567.1% $4.6M-80.1% $23.1M+132.6% $9.9M-70.5% $33.8M+2.8% $32.8M+185.7% $11.5M
Financing Cash Flow -$12.5M+63.4% -$34.2M-279.5% -$9.0M+17.9% -$11.0M-47.4% -$7.4M+88.4% -$64.2M-679.7% -$8.2M+29.4% -$11.7M
Dividends Paid $7.8M-80.7% $40.3M+436.9% $7.5M+0.2% $7.5M+0.8% $7.4M-85.1% $49.7M+601.2% $7.1M-0.1% $7.1M
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

AMSF Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin 10.2%-2.6pp 12.7%-4.1pp 16.9%-0.4pp 17.2%+4.9pp 12.3%-5.4pp 17.8%-0.4pp 18.2%+3.7pp 14.5%
Return on Equity 3.3%-0.8pp 4.1%-0.9pp 5.0%-0.2pp 5.3%+1.8pp 3.4%-1.7pp 5.1%+0.5pp 4.6%+0.9pp 3.6%
Return on Assets 0.7%-0.2pp 0.9%-0.3pp 1.2%-0.0pp 1.2%+0.4pp 0.8%-0.4pp 1.1%0.0pp 1.1%+0.3pp 0.9%
Current Ratio N/A N/A N/A N/A N/A N/A N/A N/A
Debt-to-Equity 3.55+0.1 3.49+0.3 3.24-0.1 3.35-0.1 3.44-0.1 3.50+0.5 2.99-0.1 3.10
FCF Margin -3.4%-16.2pp 12.8%+0.9pp 11.9%+23.7pp -11.8%-9.3pp -2.5%-17.1pp 14.6%+3.9pp 10.7%+14.2pp -3.5%

Similar Companies

Frequently Asked Questions

Amerisafe (AMSF) reported $317.3M in total revenue for fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Amerisafe (AMSF) revenue grew by 2.7% year-over-year, from $309.0M to $317.3M in fiscal year 2025.

Yes, Amerisafe (AMSF) reported a net income of $47.1M in fiscal year 2025, with a net profit margin of 14.8%.

Amerisafe (AMSF) reported diluted earnings per share of $2.47 for fiscal year 2025. This represents a -14.5% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amerisafe (AMSF) had a net profit margin of 14.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Amerisafe (AMSF) paid $1.56 per share in dividends during fiscal year 2025.

Amerisafe (AMSF) has a return on equity of 18.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Amerisafe (AMSF) generated $8.9M in free cash flow during fiscal year 2025. This represents a -61.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Amerisafe (AMSF) generated $11.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Amerisafe (AMSF) had $1.1B in total assets as of fiscal year 2025, including both current and long-term assets.

Amerisafe (AMSF) invested $2.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Amerisafe (AMSF) had 19M shares outstanding as of fiscal year 2025.

Amerisafe (AMSF) had a debt-to-equity ratio of 3.49 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Amerisafe (AMSF) had a return on assets of 4.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Amerisafe (AMSF) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Amerisafe (AMSF) has an earnings quality ratio of 0.24x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Amerisafe (AMSF) scores 27 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top